FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
1-Year Est. Return 24.36%
This Quarter Est. Return
1 Year Est. Return
-24.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
+$12.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
6
New
Increased
Reduced
Closed

Top Buys

1 +$5.01M

Top Sells

1 +$1.7M
2 +$9

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHVS icon
1
Pharvaris
PHVS
$1.52B
$77.6M 62.7%
4,410,581
MAZE
2
Maze Therapeutics
MAZE
$1.46B
$25.9M 20.93%
2,111,919
LYEL icon
3
Lyell Immunopharma
LYEL
$335M
$7.08M 5.72%
800,399
-1
XENE icon
4
Xenon Pharmaceuticals
XENE
$3.35B
$5.01M 4.05%
+160,000
KURA icon
5
Kura Oncology
KURA
$854M
$4.71M 3.81%
816,882
-295,000
RLAY icon
6
Relay Therapeutics
RLAY
$1.21B
$3.46M 2.79%
1,000,000